Researchers say study findings may lead to a more promising future for cell therapy targeting stroke and other neurological disorders.

Maternal prenatal stress related to natural and human-made disasters can lead to epigenetic modifications in offspring, ...

ElevateBio Life Edit (R) is the Company's gene editing technologies and R&D business, focused on building the world's largest gene editing toolbox to expand addressable diseases and open a new ...

Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many ...

A giant functional atlas of immune cells in a Chinese cohort reveals crucial differences with European and Japanese data sets ...

Early detection of declining forest health is critical for the timely intervention and treatment of droughted and diseased ...

Scientists have long suspected that the trillions of microbes in our intestines do more than digest lunch, but new work goes ...

Some parts of our bodies bounce back from injury in fairly short order. The outer protective layer of the eye-called the ...

Lexeo says the collaboration will accelerate the development of an unnamed preclinical cardiac gene therapy target.

Noetik CEO and co-founder Ron Alfa, M.D., Ph.D., said the licensing of human foundation models is “a new paradigm in biotech.” With the GSK deal validating the paradigm, in Alfa’s view, Noetik ...

Impella, which J&J touts as the world’s smallest heart pump, has a range of devices used for various heart conditions. Lexeo ...

Inducible promoters provide remarkable utility when sustained transgene expression compromises plant development or agronomic performance.